2-(Trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid

Catalog No. :
ACXRCO431
CAS No. :
241154-08-5
Molecular Formula :
C10H5F3N2O2
Molecular Weight :
242.16

IUPAC Name:2-(trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid

2-(Trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$89.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid
IUPAC Name2-(trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid
MDL No.MFCD00202890
Molecular FormulaC10H5F3N2O2
Molecular Weight242.16
SMILESO=C(C1=CC2=CC=CN=C2N=C1C(F)(F)F)O
InChI KeyVADNFSJODZWNRD-UHFFFAOYSA-N
Synonym2-(TRIFLUOROMETHYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID;2-(TRIFLUOROMETHYL)-1,8-NAPTHYRIDINE-3-CARBOXYLIC ACID;1,8-Naphthyridine-3-carboxylicacid,2-(trifluoromethyl)-(9CI);3-Carboxy-2-(trifluoromethyl)-1,8-naphthyridine;2-(Trifluoromethyl)-1,8-napthyridine-3-carboxylic;2-(Trifluoromethyl)-1,8-nahthyridine-3-carboxylic Acid;2-(Trifluoromethyl)-1,8-naphthyridine-3-carboxylic acid 95+%;1,8-Naphthyridine-3-carboxylic acid, 2-(trifluoromethyl)-
CAS No.241154-08-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACXRCO431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJHLZ504 route compound structure diagram
    ACJHLZ504252959-76-5 In Stock
  2. Then
  3. ACXRCO431 route product structure diagram
    ACXRCO431241154-08-5
Inquiry

2. ACXRCO431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXRCO431 route product structure diagram
    ACXRCO431241154-08-5
Inquiry

Comments (0)